HSBC has initiated coverage on recently listed Manipal Health with a Buy rating and Rs 1,000 target price, implying 26% upside. The brokerage sees strong growth potential from improving hospital utilisation, the Sahyadri turnaround, higher-margin speciality mix and deleveraging, with adjusted PAT expected to nearly triple by FY29.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.